A role for IRF8 in B cell anergy

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 6222-6230

  Pathak, Simanta ^a   Ma, Shibin ^a   Shukla, Vipul ^a   Lu, Runqing ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DOUBLE STRANDED DNA; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; LYSOZYME;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL MATURATION; CELL STIMULATION; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE;

EID: 84890394074     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301169     Document Type: Article

References (46)

1. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
2. Yarkoni, Y., A. Getahun, and J. C. Cambier. 2010. Molecular underpinning of B-cell anergy. Immunol. Rev. 237: 249-263.
3. Nemazee, D. 2006. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6: 728-740.
4. O'Neill, S. K., A. Getahun, S. B. Gauld, K. T. Merrell, I. Tamir, M. J. Smith, J. M. Dal Porto, Q. Z. Li, and J. C. Cambier. 2011. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity 35: 746-756.
5. Browne, C. D., C. J. Del Nagro, M. H. Cato, H. S. Dengler, and R. C. Rickert. 2009. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. Immunity 31: 749-760.
6. Kitaura, Y., I. K. Jang, Y. Wang, Y. C. Han, T. Inazu, E. J. Cadera, M. Schlissel, R. R. Hardy, and H. Gu. 2007. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity 26: 567-578.
7. Mecklenbräuker, I., K. Saijo, N. Y. Zheng, M. Leitges, and A. Tarakhovsky. 2002. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416: 860-865.
8. Mackay, F., P. Schneider, P. Rennert, and J. Browning. 2003. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21: 231-264.
9. Lesley, R., Y. Xu, S. L. Kalled, D. M. Hess, S. R. Schwab, H. B. Shu, and J. G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20: 441-453.
10. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798.
11. Oliver, P. M., T. Vass, J. Kappler, and P. Marrack. 2006. Loss of the proapoptotic protein, Bim, breaks B cell anergy. J. Exp. Med. 203: 731-741.
12. Barrington, R. A., M. Borde, A. Rao, and M. C. Carroll. 2006. Involvement of NFAT1 in B cell self-tolerance. J. Immunol. 177: 1510-1515.
13. Borde, M., R. A. Barrington, V. Heissmeyer, M. C. Carroll, and A. Rao. 2006. Transcriptional basis of lymphocyte tolerance. Immunol. Rev. 210: 105-119.
14. Peng, S. L., A. J. Gerth, A. M. Ranger, and L. H. Glimcher. 2001. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14: 13-20.
15. de Alboran, I. M., R. C. O'Hagan, F. Gärtner, B. Malynn, L. Davidson, R. Rickert, K. Rajewsky, R. A. DePinho, and F. W. Alt. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55.
16. Glynne, R., G. Ghandour, J. Rayner, D. H. Mack, and C. C. Goodnow. 2000. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176: 216-246.
17. Refaeli, Y., K. A. Field, B. C. Turner, A. Trumpp, and J. M. Bishop. 2005. The protooncogene MYC can break B cell tolerance. Proc. Natl. Acad. Sci. USA 102: 4097-4102.
18. Lu, R. 2008. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 29: 487-492.
19. Tamura, T., T. Nagamura-Inoue, Z. Shmeltzer, T. Kuwata, and K. Ozato. 2000. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13: 155-165.
20. Wang, H., C. H. Lee, C. Qi, P. Tailor, J. Feng, S. Abbasi, T. Atsumi, and H. C. Morse, III. 2008. IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112: 4028-4038.
21. Ma, S., S. Pathak, M. Mandal, L. Trinh, M. R. Clark, and R. Lu. 2010. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol. Cell. Biol. 30: 4149-4158.
22. Ma, S., S. Pathak, L. Trinh, and R. Lu. 2008. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 111: 1396-1403.
23. Ma, S., A. Turetsky, L. Trinh, and R. Lu. 2006. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J. Immunol. 177: 7898-7904.
24. Lee, C. H., M. Melchers, H. Wang, T. A. Torrey, R. Slota, C. F. Qi, J. Y. Kim, P. Lugar, H. J. Kong, L. Farrington, et al. 2006. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J. Exp. Med. 203: 63-72.
25. Feng, J., H. Wang, D. M. Shin, M. Masiuk, C. F. Qi, and H. C. Morse, III. 2011. IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J. Immunol. 186: 1458-1466.
26. Hardy, R. R. 2006. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr. Opin. Immunol. 18: 547-555.
27. Lu, R., K. L. Medina, D. W. Lancki, and H. Singh. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17: 1703-1708.
28. Kumar, K. R., L. Li, M. Yan, M. Bhaskarabhatla, A. B. Mobley, C. Nguyen, J. M. Mooney, J. D. Schatzle, E. K. Wakeland, and C. Mohan. 2006. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312: 1665-1669.
29. Pathak, S., S. Ma, L. Trinh, J. D. Eudy, K. Wagner, S. S. Joshi, and R. Lu. 2011. IRF4 is a suppressor of c-Myc induced leukemia. PLoS ONE 6: e22628.
30. Belteki, G., J. Haigh, N. Kabacs, K. Haigh, K. Sison, F. Costantini, J. Whitsett, S. E. Quaggin, and A. Nagy. 2005. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33: e51.
31. Ma, S., V. Shukla, L. Fang, K. A. Gould, S. S. Joshi, and R. Lu. 2013. Accelerated development of chronic lymphocytic leukemia in new zealand black mice expressing a low level of interferon regulatory factor 4. J. Biol. Chem. 288: 26430-26440.
32. Shukla, V., S. Ma, R. R. Hardy, S. S. Joshi, and R. Lu. 2013. A role for IRF4 in the development of CLL. Blood 122: 2848-2855.
33. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
34. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
35. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195: 181-188.
36. Burchert, A., D. Cai, L. C. Hofbauer, M. K. Samuelsson, E. P. Slater, J. Duyster, M. Ritter, A. Hochhaus, R. Müller, M. Eilers, et al. 2004. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and downregulates bcl-2. Blood 103: 3480-3489.
37. Hu, X., D. Yang, M. Zimmerman, F. Liu, J. Yang, S. Kannan, A. Burchert, Z. Szulc, A. Bielawska, K. Ozato, et al. 2011. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 71: 2882-2891.
38. Yang, J., X. Hu, M. Zimmerman, C. M. Torres, D. Yang, S. B. Smith, and K. Liu. 2011. Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells. J. Immunol. 187: 4426-4430.
39. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
40. Cunninghame Graham, D. S., D. L. Morris, T. R. Bhangale, L. A. Criswell, A. C. Syvänen, L. Rönnblom, T. W. Behrens, R. R. Graham, and T. J. Vyse. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7: e1002341.
41. Lessard, C. J., I. Adrianto, J. A. Ice, G. B. Wiley, J. A. Kelly, S. B. Glenn, A. J. Adler, H. Li, A. Rasmussen, A. H. Williams, et al BIOLUPUS Network; GENLES Network. 2012. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90: 648-660.
42. Baccala, R., R. Gonzalez-Quintial, A. L. Blasius, I. Rimann, K. Ozato, D. H. Kono, B. Beutler, and A. N. Theofilopoulos. 2013. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl. Acad. Sci. USA 110: 2940-2945.
43. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428.
44. Nickerson, K. M., S. R. Christensen, J. Shupe, M. Kashgarian, D. Kim, K. Elkon, and M. J. Shlomchik. 2010. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184: 1840-1848.
45. Subramanian, S., K. Tus, Q. Z. Li, A. Wang, X. H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103: 9970-9975.
46. Isnardi, I., Y. S. Ng, I. Srdanovic, R. Motaghedi, S. Rudchenko, H. von Bernuth, S. Y. Zhang, A. Puel, E. Jouanguy, C. Picard, et al. 2008. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29: 746-757.